Physician profile

Corrine E Renne

Foot Surgery · Franklin Square, NY

NPI 1740456169

$19,709.26

in general payments reported to CMS, 2019-2025

40 companies · $697 in 2025

The $697 reported for 2025 was more than what 80% of Foot Surgery providers received nationally (typical 2025 total: $180).

See the full distribution for Foot Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,509.80
Travel and Lodging$1,198.15

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medimetriks Pharmaceuticals, INC. $4,149.36 2019-2022
Zimmer Biomet Holdings, INC. $2,367.12 2019-2022
Abbott Laboratories $1,506.86 2019-2025 Supera, Esprit
Anika Therapeutics, INC. $1,297.99 2022-2023 Fna Products
Arthrosurface Incorporated $1,141.53 2019
Smith+Nephew, INC. $1,118.93 2021-2023 Versajet, Collagenase Santyl, Pico
Treace Medical Concepts, INC. $1,082.21 2021-2024
Nevro Corp. $764.89 2022-2024 Senza
Medtronic Vascular, INC. $662.72 2019-2020
Baxter Healthcare $637.38 2019-2021
Bolton Medical INC $442.72 2019
Advanced Oxygen Therapy INC. $436.37 2022-2025 Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities
Organogenesis INC. $356.15 2022-2023 Puraply
Orthofix Medical, INC. $315.42 2019-2020
Medtronic, INC. $273.05 2022-2024 Hawkone, Intellis Adaptivestim
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Celularity INC. $267.00 2019
Angiodynamics, INC. $252.31 2023-2024 Auryon Laser System 100-120 Vac
Bone Support INC. $249.23 2022-2024 Cerament G, Ceramentbone Void Filler
Acumed LLC $227.29 2022-2023 Osteomed, Acumed
Bioventus LLC $201.63 2021-2025 Exogen Ultrasound Bone Healing System
Access Pro Medical, LLC $198.21 2023 Matriderm
Paratek Pharmaceuticals, INC. $173.00 2021-2024 Nuzyra
Stryker Corporation $172.41 2025 Variax, Prostep Mica, Ortholoc 3di
Horizon Therapeutics Plc $167.14 2019-2020
Amgen INC. $135.26 2019-2025 Krystexxa
Allergan, INC. $125.00 2019
Osiris Therapeutics INC. $124.08 2019
Stability Biologics, LLC $123.70 2021
Kci USA, INC. $121.43 2019
Grt US Holding, INC. $121.17 2022
Triad Life Sciences INC. $109.13 2022
Averitas Pharma INC. $90.05 2023-2024 Qutenza
Djo, LLC $66.75 2025 Cmf
Kerecis Limited $46.89 2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide
Ortho Dermatologics, A Division of Bausch Health US, LLC $46.47 2023-2024 Jublia
Glenmark Therapeutics INC. $36.00 2019
Melinta Therapeutics, LLC $29.33 2019
Avanos Medical $26.36 2019
Convatec INC. $25.00 2021
Sebela Pharmaceuticals INC. $21.72 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Corrine E Renne

$19,709.26

in general payments reported 2019-2025

Years
2019-2025
Top company
Medimetriks Pharmaceuticals, INC.
Context
The $697 reported for 2025 was more than what 80% of Foot Surgery providers received nationally (typical 2025 total: $180).

https://glasscript.com/doctor/215580/corrine-e-renne

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.